Trials / Unknown
UnknownNCT00040430
Study of 111In-DAC as a Medical Imaging Agent for the Detection of Breast Cancer
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Copharos · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the safety and imaging ability of 111In-DAC when used with planar and SPECT imaging for the detection of breast cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 111In-DAC | |
| PROCEDURE | Diagnostic |
Timeline
- First posted
- 2002-06-28
- Last updated
- 2005-06-24
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00040430. Inclusion in this directory is not an endorsement.